Hochhaus, A., & Müller, M. C. (2016). Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: Results from the European ENEST1st study. Leukemia, 30(1), . https://doi.org/10.1038/leu.2015.270
Chicago-Zitierstil (17. Ausg.)Hochhaus, Andreas, und Martin Christian Müller. "Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase: Results from the European ENEST1st Study." Leukemia 30, no. 1 (2016). https://doi.org/10.1038/leu.2015.270.
MLA-Zitierstil (9. Ausg.)Hochhaus, Andreas, und Martin Christian Müller. "Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase: Results from the European ENEST1st Study." Leukemia, vol. 30, no. 1, 2016, https://doi.org/10.1038/leu.2015.270.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.